Common use of Covenant to Comply with Applicable Laws Upon Purchase of Notes Clause in Contracts

Covenant to Comply with Applicable Laws Upon Purchase of Notes. In connection with any purchase offer pursuant to Section 9.01, the Company shall, if required thereby: (a) comply with the provisions of Rule 13e-4, Rule 14e-1 and any other tender offer rules under the Exchange Act that may then be applicable; (b) file a Schedule TO or any successor or similar schedule; and (c) otherwise comply with all federal and state securities laws in connection with any offer by the Company to purchase the Notes; in each case, so as to permit the rights and obligations under this Article 9 to be exercised in the time and in the manner specified in this Article 9.

Appears in 3 contracts

Sources: Third Supplemental Indenture (Alcoa Inc.), Third Supplemental Indenture (Rti International Metals Inc), First Supplemental Indenture (Rti International Metals Inc)

Covenant to Comply with Applicable Laws Upon Purchase of Notes. In connection with any offer to purchase offer pursuant to Notes under Section 9.019.1, the Company shall, in each case if required thereby: by law, (ai) comply with the provisions of Rule 13e-4, Rule 14e-1 Regulation 14E and any other tender offer rules under the Exchange Act that may then be applicable; , (bii) file a Schedule TO or any successor or similar schedule; and other required schedule under the Exchange Act and (ciii) otherwise comply with all U.S. federal and or state securities laws applicable to the Company in connection with any offer by the Company to such purchase the Notes; offer, in each case, so as to permit the rights and obligations under this Article Section 9 to be exercised in the time and in the manner specified in under this Article Section 9.

Appears in 3 contracts

Sources: Note Purchase Agreement (Heron Therapeutics, Inc. /De/), Note Purchase Agreement (Rubric Capital Management LP), Note Purchase Agreement (Heron Therapeutics, Inc. /De/)

Covenant to Comply with Applicable Laws Upon Purchase of Notes. In connection with any offer to purchase offer pursuant to Notes under Section 9.01‎10.1, the Company shall, in each case if required thereby: by law, (a) comply with the provisions of Rule 13e-4, Rule 14e-1 Regulation 14E and any other tender offer rules under the Exchange Act that may then be applicable; , (b) file a Schedule TO or any successor or similar schedule; and other required schedule under the Exchange Act and (c) otherwise comply with all U.S. federal and or state securities laws applicable to the Company in connection with any offer by the Company to such purchase the Notes; offer, in each case, so as to permit the rights and obligations under this Article 9 Section ‎10 to be exercised in the time and in the manner specified in under this Article 9Section ‎10.

Appears in 2 contracts

Sources: Note Purchase Agreement (Allurion Technologies, Inc.), Note Purchase Agreement (Milestone Pharmaceuticals Inc.)

Covenant to Comply with Applicable Laws Upon Purchase of Notes. In connection with any purchase offer pursuant to Section 9.01offer, the Company shallwill, if required therebyto the extent required: (a) comply with the provisions of Rule 13e-4, Rule 14e-1 and any other tender offer rules under the Exchange Act that may then be applicable; (b) file a Schedule TO or any successor or similar scheduleschedule required under the Exchange Act; and (c) otherwise comply with all applicable federal and state securities laws in connection with any offer by the Company to purchase the Notes; in each case, so as to permit the rights and obligations under this Article 9 15 to be exercised in the time and in the manner specified in this Article 915.

Appears in 2 contracts

Sources: Indenture (Ionis Pharmaceuticals Inc), Indenture (Isis Pharmaceuticals Inc)

Covenant to Comply with Applicable Laws Upon Purchase of Notes. In connection with any purchase offer pursuant to Section 9.01a Fundamental Change Company Notice, the Company shall, if required therebyrequired: (a) comply with the provisions of Rule 13e-4, Rule 14e-1 and any other the tender offer rules under the Exchange Act that may then be applicable; (b) file a Schedule TO or any successor or similar scheduleother required schedule under the Exchange Act; and (c) otherwise comply with all federal and state securities laws in connection with any offer by the Company to purchase the Notes; in each case, so as to permit the rights and obligations under this Article 9 10 to be exercised in the time and in the manner specified in this Article 910.

Appears in 2 contracts

Sources: Fifth Supplemental Indenture (Tesla, Inc.), Fourth Supplemental Indenture (Tesla, Inc.)

Covenant to Comply with Applicable Laws Upon Purchase of Notes. In connection with any purchase offer pursuant to Section 9.01offer, the Company shallwill, if required therebyrequired: (a) comply with the provisions of Rule 13e-4, Rule 14e-1 and any other tender offer rules under the Exchange Act that may then be applicableAct; (b) file a Schedule TO or any successor or similar scheduleother required schedule under the Exchange Act; and (c) otherwise comply with all federal and state securities laws in connection with any offer by the Company to purchase the Notes; in each case, so as to permit the rights and obligations under this Article 9 15 to be exercised in the time and in the manner specified in this Article 915.

Appears in 2 contracts

Sources: Indenture (Incyte Corp), Indenture (Incyte Corp)

Covenant to Comply with Applicable Laws Upon Purchase of Notes. In connection with any purchase offer pursuant to Section 9.01a Fundamental Change Company Notice, the Company shall, if required therebyrequired: (a) comply with the provisions of Rule 13e-4, Rule 14e-1 and any other tender offer rules under the Exchange Act that may then be applicable; (b) file a Schedule TO or any successor or similar scheduleother required schedule under the Exchange Act; and (c) otherwise comply with all federal and state securities laws in connection with any offer by the Company to purchase the Notes; in each case, so as to permit the rights and obligations under this Article 9 10 to be exercised in the time and in the manner specified in this Article 910.

Appears in 2 contracts

Sources: Second Supplemental Indenture (Tesla Motors Inc), Third Supplemental Indenture (Tesla Motors Inc)

Covenant to Comply with Applicable Laws Upon Purchase of Notes. In connection with any purchase offer pursuant to Section 9.01offer, the Company shallwill, if required therebyto the extent required: (a) comply with the provisions of Rule 13e-4, Rule 14e-1 and any other tender offer rules under the Exchange Act that may then be applicable; (b) file a Schedule TO or any successor or similar scheduleschedule required under the Exchange Act; and (c) otherwise comply with all federal and state securities laws in connection with any offer by the Company to purchase the Notes; in each case, so as to permit the rights and obligations under this Article 9 15 to be exercised in the time and in the manner specified in this Article 915.

Appears in 2 contracts

Sources: Indenture (Isis Pharmaceuticals Inc), Indenture (Conceptus Inc)

Covenant to Comply with Applicable Laws Upon Purchase of Notes. In connection with any offer to purchase offer pursuant to Notes under Section 9.0110.1, the Company shall, in each case if required thereby: by law, (ai) comply with the provisions of Rule 13e-4, Rule 14e-1 Regulation 14E and any other tender offer rules under the Exchange Act that may then be applicable; , (bii) file a Schedule TO or any successor or similar schedule; and other required schedule under the Exchange Act and (ciii) otherwise comply with all U.S. federal and or state securities laws applicable to the Company in connection with any offer by the Company to such purchase the Notes; offer, in each case, so as to permit the rights and obligations under this Article 9 Section 10 to be exercised in the time and in the manner specified in under this Article 9Section 10.

Appears in 1 contract

Sources: Note Purchase Agreement (Heron Therapeutics, Inc. /De/)